Total Payments
$620,868
2024 Payments
$58,377
Companies
22
Transactions
909
Medicare Patients
2,382
Medicare Billing
$742,598
Payment Breakdown by Category
Other$500,757 (80.7%)
Consulting$64,943 (10.5%)
Travel$39,825 (6.4%)
Food & Beverage$13,735 (2.2%)
Education$1,600 (0.3%)
Research$9.33 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $468,567 | 227 | 75.5% |
| Consulting Fee | $64,943 | 26 | 10.5% |
| Travel and Lodging | $39,825 | 143 | 6.4% |
| Honoraria | $32,190 | 17 | 5.2% |
| Food and Beverage | $13,735 | 490 | 2.2% |
| Education | $1,600 | 5 | 0.3% |
| Unspecified | $9.33 | 1 | 0.0% |
Payments by Type
General
$620,859
908 transactions
Research
$9.33
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $275,864 | 330 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $109,847 | 133 | $0 (2024) |
| MDD US Operations, LLC | $101,702 | 212 | $0 (2024) |
| Acorda Therapeutics, Inc | $43,510 | 40 | $0 (2024) |
| Kyowa Kirin, Inc. | $38,044 | 32 | $0 (2024) |
| Adamas Pharmaceuticals, Inc. | $34,857 | 28 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $8,810 | 22 | $0 (2022) |
| US WorldMeds, LLC | $5,551 | 52 | $0 (2020) |
| Amneal Pharmaceuticals LLC | $1,519 | 8 | $0 (2024) |
| ABBVIE INC. | $356.53 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $58,377 | 112 | Neurocrine Biosciences, Inc. ($25,186) |
| 2023 | $90,471 | 124 | MDD US Operations, LLC ($34,185) |
| 2022 | $105,069 | 123 | Neurocrine Biosciences, Inc. ($48,599) |
| 2021 | $91,213 | 141 | Neurocrine Biosciences, Inc. ($24,204) |
| 2020 | $49,244 | 76 | Teva Pharmaceuticals USA, Inc. ($13,568) |
| 2019 | $101,354 | 181 | Neurocrine Biosciences, Inc. ($74,056) |
| 2018 | $105,762 | 124 | Neurocrine Biosciences, Inc. ($69,715) |
| 2017 | $19,379 | 28 | Teva Pharmaceuticals USA, Inc. ($17,415) |
All Payment Transactions
909 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: Musculoskeletal | ||||||
| 12/02/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/01/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $9.47 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 12/01/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 12/01/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $7.62 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/04/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/04/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $8.25 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/04/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/04/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 10/24/2024 | ABBVIE INC. | VYALEV (Drug), DUOPA | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Amneal Pharmaceuticals LLC | ONGENTYS 50MG CAPSULES 30 (Drug) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: NEUROLOGY | ||||||
| 10/08/2024 | Merz Pharmaceuticals, LLC | INBRIJA (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Parkinson's Disease | ||||||
| 10/07/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 10/07/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $9.13 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 10/07/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 10/07/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 09/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Neuropsychiatry | ||||||
| 09/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,445.00 | General |
| Category: Neuropsychiatry | ||||||
| 09/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Central Nervous System | ||||||
| 09/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,240.00 | General |
| Category: Neuropsychiatry | ||||||
| 09/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,445.00 | General |
| Category: Neuropsychiatry | ||||||
| 09/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $113.90 | General |
| Category: Neuropsychiatry | ||||||
| 09/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: Neuropsychiatry | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| EFFECT OF LY3154207 ON COGNITION IN MILD TO MODERATE PARKINSONS DISEASE DEMENTIA PDD - THE PRESENCE STUDY | Eli Lilly and Company | $9.33 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 737 | 24,945 | $363,803 | $218,780 |
| 2022 | 13 | 611 | 24,406 | $311,674 | $185,994 |
| 2021 | 11 | 554 | 23,679 | $295,022 | $188,194 |
| 2020 | 13 | 480 | 20,281 | $249,964 | $149,630 |
Total Patients
2,382
Total Services
93,311
Medicare Billing
$742,598
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2023 | 37 | 16,618 | $105,195 | $66,778 | 63.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 226 | 385 | $87,147 | $48,759 | 56.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 12 | 5,150 | $41,200 | $25,584 | 62.1% |
| J0587 | Injection, rimabotulinumtoxinb, 100 units | Office | 2023 | 14 | 2,175 | $33,169 | $21,677 | 65.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 46 | 46 | $22,403 | $13,162 | 58.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 125 | $19,949 | $10,607 | 53.2% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2023 | 46 | 46 | $16,251 | $9,683 | 59.6% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 22 | 67 | $11,128 | $6,821 | 61.3% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 21 | 51 | $8,999 | $4,730 | 52.6% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 11 | 27 | $4,342 | $3,111 | 71.6% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2023 | 12 | 32 | $3,543 | $2,272 | 64.1% |
| 64611 | Injection of chemical for paralysis of salivary glands on both sides of mouth | Office | 2023 | 15 | 27 | $4,203 | $2,160 | 51.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 63 | 82 | $3,585 | $1,973 | 55.0% |
| 92552 | Test for hearing various pitches using earphone | Office | 2023 | 46 | 46 | $2,059 | $1,227 | 59.6% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 64 | 68 | $631.80 | $236.64 | 37.5% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2022 | 33 | 16,520 | $102,036 | $63,335 | 62.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 231 | 462 | $102,102 | $58,635 | 57.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 20 | 6,933 | $55,364 | $33,632 | 60.7% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 23 | 74 | $11,840 | $7,381 | 62.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 54 | $8,532 | $4,389 | 51.4% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2022 | 21 | 49 | $8,025 | $4,012 | 50.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 93 | 119 | $5,355 | $2,955 | 55.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 30 | 30 | $4,800 | $2,922 | 60.9% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2022 | 30 | 59 | $3,835 | $2,690 | 70.1% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2022 | 15 | 33 | $3,401 | $2,383 | 70.1% |
About Dr. Sanjay Iyer, MD
Dr. Sanjay Iyer, MD is a Neurology healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376561472.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sanjay Iyer, MD has received a total of $620,868 in payments from pharmaceutical and medical device companies, with $58,377 received in 2024. These payments were reported across 909 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($468,567).
As a Medicare-enrolled provider, Iyer has provided services to 2,382 Medicare beneficiaries, totaling 93,311 services with total Medicare billing of $742,598. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Charlotte, NC
- Active Since 07/17/2006
- Last Updated 12/01/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1376561472
Products in Payments
- INGREZZA (Drug) $269,155
- GOCOVRI (Drug) $86,309
- AUSTEDO (Drug) $82,552
- INBRIJA (Drug) $43,269
- NOURIANZ (Drug) $27,876
- Austedo XR (Drug) $23,530
- APOKYN (Drug) $22,478
- MYOBLOC (Drug) $11,017
- Nourianz (Drug) $10,167
- Apokyn (Drug) $8,668
- KYNMOBI (Drug) $7,257
- Ongentys (Drug) $5,109
- SD809-HD (Drug) $3,560
- Gocovri (Drug) $3,529
- Myobloc (Drug) $3,250
- MYOBLOC (Biological) $3,016
- LONHALA MAGNAIR (Drug) $1,500
- ONGENTYS 50MG CAPSULES 30 (Drug) $939.39
- ONGENTYS (Drug) $466.00
- XADAGO (Drug) $452.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Charlotte
Jill Conway, Md, MD
Neurology — Payments: $1.5M
Neurology $1.5M
Dr. Megan Donnelly, D.o, D.O
Neurology — Payments: $471,292
Neurology $471,292
Danielle Englert Doggett, Md, MD
Neurology — Payments: $224,230
Neurology $224,230
Ardith Courtney, Do, DO
Neurology — Payments: $215,565
Neurology $215,565
Mohammad Bolouri, Md, MD
Neurology — Payments: $184,450
Neurology $184,450
Joseph Chipman, Md, MD
Neurology — Payments: $120,418
Neurology $120,418